Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 2/3 3Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Neoplasms 18Prostatic Neoplasms 16Breast Neoplasms 11Recurrence 8Leukemia, Myeloid, Acute 8Neoplasm Metastasis 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Colorectal Neoplasms 6Ovarian Neoplasms 5Myelodysplastic Syndromes 5Multiple Myeloma 5Melanoma 5Leukemia 5Head and Neck Neoplasms 5Lymphoma, Non-Hodgkin 4Lung Neoplasms 4Fatigue 4Carcinoma, Non-Small-Cell Lung 4Vomiting 3Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms, Castration-Resistant 3Pain 3Oropharyngeal Neoplasms 3Nausea 3Mesothelioma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Liposarcoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Has results × Prostatic Neoplasms, Castration-Resistant × Clear all
NCT03822845 2025-04-17

Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

University of Iowa

Phase 2/3 Completed
6 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03389451 2024-07-12

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

University of Iowa

Phase 2/3 Completed
30 enrolled 10 charts
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03388346 2024-02-15

68Ga PSMA in Preprostatectomy Patients

University of Iowa

Phase 2/3 Completed
22 enrolled 15 charts
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡